ArticleJournal of gastrointestinal oncology2026
Clinical efficacy and safety of apatinib plus S-1 combined with oxaliplatin (SOX) in postoperative stage III gastric cancer patients with high VEGFR-2 expression.
Qin Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.